Ignite Creation Date:
2024-05-06 @ 7:02 PM
Last Modification Date:
2024-10-26 @ 2:59 PM
Study NCT ID:
NCT05871268
Status:
RECRUITING
Last Update Posted:
2024-03-12
First Post:
2023-05-12
Brief Title:
Bridging the Health Disparities Gap in Decision-Making Among Limited English Proficient LEP Patients With Pelvic Floor Disorders
Sponsor:
Loyola University
Organization:
Loyola University
Study Overview
Official Title:
Bridging the Health Disparities Gap in Decision-Making Among Limited English Proficient LEP Patients With Pelvic Floor Disorders
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Understanding a patients decision-making preference can help physicians meet their expectations and may increase patient satisfaction with the decision-making process
Detailed Description:
Effective communication between patients and physicians is critical to successful health outcomes Limited English proficiency LEP is defined by the US Census Bureau as anyone who reported speaking English less than very well There are more than 25 million people approximately 1 in 11 Americans with LEP in the United States1 LEP patients are among the most vulnerable populations The language barrier experienced by LEP patients hinders effective communication impedes access to care and impacts health care delivery6 Research has shown that LEP patients are likely to consume more health care services7 however they receive lower quality of care and have poorer outcomes compared to English-proficient patients on various measures understanding of treatment plans and diseases processes satisfaction and incidence of medical errors35 This language-based inequity in LEP patients also hampers shared decision-making a process in which physicians and patients make decisions together balancing the risks and benefits with patient preferences and values6-7 Shared decision-making is encouraged by the Institute of Medicine and US Preventative Services to foster patient autonomy and engagement6 Similarly the American College of Obstetricians and Gynecologists emphasizes the importance of creating a partnership with patients7 Research indicates that patients want to be more involved in the decision-making process but might feel that they do not have the capability to do so8 Furthermore the ability of patients to engage in the shared decision-making process also depends on their health literacy It is estimated that one-third to one-half of the US adult population has low health literacy or a limited capacity to obtain process and understand the basic health information and services needed to make informed health decisions8 While low health literacy affects individuals across the spectrum of socio-demographics it disproportionately affects those with LEP9 A knowledge gap exists in our understanding of LEP patients roles in decision-making since most research on decision-making itself often excludes non-English speakers from study participation The few published reports in the oncology literature have suggested that Latinas experience barriers to informed treatment decision-making related to literacy language and acculturation28 Hawley ST et al 2008 in a survey of 2030 women with breast cancer found that Spanish-preferred Latinas were more likely to report too little involvement higher dissatisfaction and more regrets compared to English-preferred Latinas African Americans and Caucasians9 Research has shown that patients who take a more active role in their care are often more satisfied have a better understanding of treatment plans and experience greater improvement in health and patient-centered outcomes than do passive patients10 Therefore understanding these preferences particularly in an LEP population is necessary to meet patients decision-making expectations navigate discussions about treatment options and increase patient satisfaction with the decision-making process
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None